You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cHL

Showing 1 - 25 of 199
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allogeneic Hematopoietic Cell Transplantation For Classical

Active, not recruiting
  • Lymphoma
  • Non-Interventional
  • Princeton, New Jersey
  • +1 more
Mar 14, 2022

Classical Hodgkin Lymphoma, Refractory or Relapsed Classical Hodgkin Lymphoma Trial in Guangzhou (PD-1 inhibitor, PD-1

Recruiting
  • Classical Hodgkin Lymphoma
  • Refractory or Relapsed Classical Hodgkin Lymphoma
  • PD-1 inhibitor
  • PD-1 inhibitor, gemcitabine, vinorelbine and doxorubicin liposome
  • Guangzhou, Guangdong, China
  • +2 more
May 6, 2022

Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Boston (Nivolumab, Ipilimumab)

Recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Oct 18, 2022

Advanced Classical Hodgkin's Lymphoma in Brazil Treated With

Not yet recruiting
  • Hodgkin Lymphoma
  • No Intervention
  • Salvador, Bahia, Brazil
  • +5 more
Oct 23, 2023

Hodgkin Lymphoma Trial (pembrolizumab)

Active, not recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • (no location specified)
May 30, 2022

Hodgkin Lymphoma Trial in Moscow (Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Moscow, Russian Federation
    The Federal Budget-Funded Institution National Medical Surgical
Oct 31, 2022

Classical Hodgkin Lymphoma Trial in Charlottesville (Pembrolizumab, Doxorubicin, Vinblastine)

Recruiting
  • Classical Hodgkin Lymphoma
  • Charlottesville, Virginia
    University of Virginia
Jul 27, 2022

Classic Hodgkin's Lymphoma Trial in Beijing (Sintilimab, Carboplatin, Etoposide)

Recruiting
  • Classic Hodgkin's Lymphoma
  • Sintilimab
  • +4 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Sep 12, 2022

Breast Cancer Trial in Esch-sur-Alzette, Luxembourg (Medication adherence eHealth intervention)

Recruiting
  • Breast Cancer
  • Medication adherence eHealth intervention
  • Esch-sur-Alzette, Luxembourg
  • +1 more
Apr 11, 2022

Mission Related to the Cohort Programme

Recruiting
  • Parkinson Disease
  • Observational study with sample and data collection
  • Luxembourg, Luxembourg
  • +1 more
Feb 23, 2022

Classical Hodgkin Lymphoma, Hodgkin Disease Refractory, Hodgkin Disease Recurrent Trial in United States (Nivolumab, Autologous

Recruiting
  • Classical Hodgkin Lymphoma
  • +2 more
  • Duarte, California
  • +4 more
Jun 27, 2022

Relapsed/Refractory Peripheral T-cell Lymphoma, Relapsed/Refractory Classical Hodgkins Lymphoma Trial in Worldwide (AZD4573)

Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Relapsed/Refractory Classical Hodgkins Lymphoma
  • Duarte, California
  • +33 more
Jan 5, 2023

Hodgkin Disease Lymphoma Trial in China (Penpulimab, Investigator's choice of Chemotherapy)

Recruiting
  • Hodgkin Disease Lymphoma
  • Guangzhou, Guangdong, China
  • +5 more
Feb 15, 2022

Idiopathic Pulmonary Fibrosis Trial in Belgium, Luxembourg

Completed
  • Idiopathic Pulmonary Fibrosis
    • Antwerp, Belgium
    • +8 more
    Feb 14, 2022

    Long COVID-19 Fatigue and Obstructive Sleep Apnea

    Recruiting
    • Long COVID
    • +2 more
    • OSA
    • Alvor, Portugal
    • +11 more
    Mar 26, 2022

    Classical Hodgkin Lymphoma Trial in Nanjing (Camrelizumab, Investigator's choice of Chemotherapy)

    Recruiting
    • Classical Hodgkin Lymphoma
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Hospital
    Feb 4, 2021

    Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

    Active, not recruiting
    • Mycobacterium Infections, Nontuberculous
    • Birmingham, Alabama
    • +110 more
    Jan 23, 2023

    Prostate Cancer Trial in Wichita, Lincoln, Omaha (SoluMatrix™ Abiraterone Acetate, Methylprednisolone)

    Completed
    • Prostate Cancer
    • Wichita, Kansas
    • +2 more
    Jul 20, 2020

    Pediatric Obesity, Obesity Trial in Chestnut Hill (Parents Connect for Healthy Living (PConnect), Enhanced Nutrition Support,

    Suspended
    • Pediatric Obesity
    • Obesity
    • Parents Connect for Healthy Living (PConnect)
    • +2 more
    • Chestnut Hill, Massachusetts
      Boston College
    Oct 29, 2020

    Prostate Cancer Trial in India (Degarelix)

    Completed
    • Prostate Cancer
    • Bikaner, Rajasthan, India
    • +18 more
    Dec 14, 2021

    Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)

    Active, not recruiting
    • Hodgkin Disease
    • Nivolumab
    • +2 more
    • Birmingham, Alabama
    • +77 more
    Jul 21, 2022

    Patterns and Disease Control in cHL and sALCL in Routine

    Completed
    • Hodgkin Disease
    • Lymphoma, Large-cell, Anaplastic
      • Astrakhan, Russian Federation
      • +49 more
      Dec 19, 2022

      Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (brentuximab vedotin)

      Terminated
      • Hodgkin Lymphoma
      • +2 more
      • brentuximab vedotin
      • Anaheim, California
      • +18 more
      Dec 6, 2022

      Obesity, Acanthosis Nigricans, Central Obesity Trial in Honolulu (CHL program, Delayed Optimized CHL program)

      Completed
      Has Results
      • Obesity
      • +2 more
      • CHL program
      • Delayed Optimized CHL program
      • Honolulu, Hawaii
        University of Hawaii
      Apr 21, 2020

      Endurant™ Stent Graft System in Treatment of Infra-renal

      Completed
      • Aneurysm
      • +5 more
      • Endurant Stent graft
      • Avignon, France
      • +19 more
      Oct 27, 2021